{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:19:50Z","timestamp":1794377990455,"version":"4.9.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In this study, a novel series of 1,2,4-triazolo[4,3-<jats:italic>a<\/jats:italic>]quinoxalines containing a sulfonamide moiety was designed and synthesized through regioselective synthesis from 2 and\/ 3-hydrazino-6-(pyrrolidin-1-ylsulfonyl)quinoxaline derivatives <jats:bold>5<\/jats:bold> and <jats:bold>7<\/jats:bold>. The structures of two isomers were confirmed and characterized by IR,<jats:sup>1<\/jats:sup>H NMR,<jats:sup>13<\/jats:sup>C NMR, and elemental analysis data. The synthesized 1,2,4-triazolo[4,3-<jats:italic>a<\/jats:italic>]quinoxaline derivatives <jats:bold>8\u201313<\/jats:bold> were evaluated for their antidiabetic activities by targeting \u03b1-amylase and \u03b1-glucosidase, as well as for their anti-Alzheimer activity by targeting acetylcholinesterase (AChE) at a concentration of 100 \u00b5M. Structure-activity relationship (SAR) analysis was conducted for all analogs, emphasizing the nature of the substituent groups at position one of the triazole nucleus and the positioning of the sulfonamide moiety. For \u03b1-amylase and \u03b1-glucosidase activity, the designed compounds exhibited moderate to good activity, with inhibitory percentage values ranging from 21.85\u2009\u00b1\u20090.01% to 64.70\u2009\u00b1\u20090.02% and from 23.93\u2009\u00b1\u20090.01% to 75.36\u2009\u00b1\u20090.01%, respectively. The <jats:italic>N<\/jats:italic>-allyl-[1,2,4]triazolo[4,3-<jats:italic>a<\/jats:italic>]quinoxalin-1-amine derivative <jats:bold>10a<\/jats:bold> demonstrated the most significant inhibitory activity, with percentages of 64.70\u2009\u00b1\u20090.02% and 75.36\u2009\u00b1\u20090.01% against \u03b1-amylase and \u03b1-glucosidase, respectively, in comparison to acarbose (IP\u2009=\u200967.33\u2009\u00b1\u20090.01% and 57.79\u2009\u00b1\u20090.01%). Furthermore, the 1,2,4-triazolo[4,3-<jats:italic>a<\/jats:italic>]quinoxaline derivatives <jats:bold>8\u201313<\/jats:bold> exhibited low to moderate inhibitory percentages against the acetylcholinesterase enzyme, except for the 1-methyl-[1,2,4]triazolo[4,3-<jats:italic>a<\/jats:italic>]quinoxaline derivative <jats:bold>11b<\/jats:bold> which demonstrated the highest inhibitory percentage of 44.78\u2009\u00b1\u20090.01%, compared to donepezil (IP\u2009=\u200967.27\u2009\u00b1\u20090.60%). Moreover, the promising derivative <jats:bold>10a<\/jats:bold> demonstrated exceptional inhibitory activity, exhibiting IC<jats:sub>50<\/jats:sub> values of 3.46\u2009\u00b1\u20090.06 \u00b5M and 6.89\u2009\u00b1\u20090.09 \u00b5M against \u03b1-glucosidase and \u03b1-amylase, respectively, when compared to acarbose, which has IC<jats:sub>50<\/jats:sub> values of 4.27\u2009\u00b1\u20090.06 \u00b5M and 5.90\u2009\u00b1\u20090.09 \u00b5M. Finally, molecular docking simulations were performed for compound <jats:bold>10a<\/jats:bold> within \u03b1-amylase (PDB: 2QV4) and \u03b1-glucosidase (PDB: 3W37), while compound <jats:bold>11b<\/jats:bold> was analyzed within acetylcholinesterase (AChE) (PDB: 4EY7) to assess binding affinity and to explore the binding interactions with the active sites of the enzymes.<\/jats:p>","DOI":"10.1038\/s41598-025-03139-9","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:26:59Z","timestamp":1748942819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exploring novel of 1,2,4-triazolo[4,3-a]quinoxaline sulfonamide regioisomers as anti-diabetic and anti-Alzheimer agents with in-silico molecular docking simulation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-3904","authenticated-orcid":false,"given":"Moustafa S.","family":"Abusaif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Sh El-Sharief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousry A.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael M.","family":"Aboulthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-5546","authenticated-orcid":false,"given":"Mohamed S. A.","family":"El-Gaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-7465","authenticated-orcid":false,"given":"Ahmed","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"3139_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications. Physiol. Rev. 93, 137\u2013188 (2013).","journal-title":"Physiol. Rev."},{"key":"3139_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1742-1241.2006.01175.x","volume":"60","author":"A Girach","year":"2006","unstructured":"Girach, A., Manner, D. & Porta, M. Diabetic microvascular complications: can patients at risk be identified? A review. Int. J. Clin. Pract. 60, 1471\u20131483 (2006).","journal-title":"Int. J. Clin. Pract."},{"key":"3139_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani, M., Van Dam, R. M., Willett, W. C. & Hu, F. B. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am. J. Epidemiol. 166, 495\u2013505 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"3139_CR4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/jnci\/dji375","volume":"97","author":"SC Larsson","year":"2005","unstructured":"Larsson, S. C., Orsini, N. & Wolk, A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J. Natl. Cancer Inst. 97, 1679\u20131687 (2005).","journal-title":"J. Natl. Cancer Inst."},{"key":"3139_CR5","doi-asserted-by":"publisher","first-page":"15691","DOI":"10.1039\/D4RA02143F","volume":"14","author":"HK Thabet","year":"2024","unstructured":"Thabet, H. K. et al. Innovation of 6-sulfonamide-2H-chromene derivatives as antidiabetic agents targeting \u03b1-amylase, \u03b1-glycosidase, and PPAR-\u03b3 inhibitors with in Silico molecular Docking simulation. RSC Adv. 14, 15691\u201315705 (2024).","journal-title":"RSC Adv."},{"key":"3139_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","volume":"108","author":"OM Ighodaro","year":"2018","unstructured":"Ighodaro, O. M. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed. Pharmacother. 108, 656\u2013662 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"3139_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058\u20131070 (2010).","journal-title":"Circ. Res."},{"key":"3139_CR8","doi-asserted-by":"publisher","first-page":"2367128","DOI":"10.1080\/14756366.2024.2367128","volume":"39","author":"NA Gohar","year":"2024","unstructured":"Gohar, N. A. et al. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting \u03b1-amylase, and \u03b1-glucosidase: synthesis, molecular docking, and ADMET studies. J. Enzyme Inhib. Med. Chem. 39, 2367128 (2024).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"3139_CR9","doi-asserted-by":"publisher","first-page":"116589","DOI":"10.1016\/j.ejmech.2024.116589","volume":"275","author":"H Khamees Thabet","year":"2024","unstructured":"Khamees Thabet, H. et al. Discovery of new anti-diabetic potential agents based on Paracetamol incorporating sulfa-drugs: design, synthesis, \u03b1-amylase, and \u03b1-glucosidase inhibitors with molecular Docking simulation. Eur. J. Med. Chem. 275, 116589 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"3139_CR10","doi-asserted-by":"publisher","first-page":"107671","DOI":"10.1016\/j.bioorg.2024.107671","volume":"151","author":"H Khamees Thabet","year":"2024","unstructured":"Khamees Thabet, H. et al. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: design, synthesis, in vitro bio-evaluation targeting DPP-4, \u03b1-glucosidase, and \u03b1-amylase with in-silico ADMET and Docking simulation. Bioorg. Chem. 151, 107671 (2024).","journal-title":"Bioorg. Chem."},{"key":"3139_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00003495-199200443-00007","volume":"44","author":"P Hollander","year":"1992","unstructured":"Hollander, P. Safety profile of acarbose, an \u03b1-glucosidase inhibitor. Drugs 44, 47\u201353 (1992).","journal-title":"Drugs"},{"key":"3139_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2165\/00003495-200059030-00012","volume":"59","author":"LJ Scott","year":"2000","unstructured":"Scott, L. J. & Spencer, C. M. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. Drugs 59, 521\u2013549 (2000).","journal-title":"Drugs"},{"key":"3139_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ddr.22008","volume":"84","author":"AS Hassan","year":"2023","unstructured":"Hassan, A. S., Morsy, N. M., Aboulthana, W. M. & Ragab, A. In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation. Drug Dev. Res. 84, 3\u201324 (2023).","journal-title":"Drug Dev. Res."},{"key":"3139_CR14","doi-asserted-by":"publisher","first-page":"e22216","DOI":"10.1002\/ddr.22216","volume":"85","author":"A Ragab","year":"2024","unstructured":"Ragab, A. et al. Explore new Quinoxaline pharmacophore tethered sulfonamide fragments as in vitro $\u03b1$-glucosidase, $\u03b1$\u2010amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation. Drug Dev. Res. 85, e22216 (2024).","journal-title":"Drug Dev. Res."},{"key":"3139_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1041610203008676","volume":"14","author":"NH Greig","year":"2002","unstructured":"Greig, N. H., Lahiri, D. K. & Sambamurti, K. Butyrylcholinesterase: an important new target in Alzheimer\u2019s disease therapy. Int. Psychogeriatr. 14, 77\u201391 (2002).","journal-title":"Int. Psychogeriatr."},{"key":"3139_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","volume":"1863","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla, R., Thirumala, V. & Reddy, P. H. Is Alzheimer\u2019s disease a type 3 diabetes?? A critical appraisal. Biochim. Biophys. Acta - Mol. Basis Dis. 1863, 1078\u20131089 (2017).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"3139_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.07.009","volume":"250","author":"Y Yang","year":"2013","unstructured":"Yang, Y. & Song, W. Molecular links between Alzheimer\u2019s disease and diabetes mellitus. Neuroscience 250, 140\u2013150 (2013).","journal-title":"Neuroscience"},{"key":"3139_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/157016309789054924","volume":"6","author":"JJ Escobar-Chavez","year":"2009","unstructured":"Escobar-Chavez, J. J. et al. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation. Curr. Drug Discov Technol. 6, 171\u2013185 (2009).","journal-title":"Curr. Drug Discov Technol."},{"key":"3139_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/jop.1985.1.101","volume":"1","author":"MA McLAUGHLIN","year":"1985","unstructured":"McLAUGHLIN, M. A. & CHIOU, G. C. Y. A synopsis of recent developments in antiglaucoma drugs. J. Ocul Pharmacol. Ther. 1, 101\u2013121 (1985).","journal-title":"J. Ocul Pharmacol. Ther."},{"key":"3139_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/2021217a0","volume":"202","author":"WB HUGO","year":"1964","unstructured":"HUGO, W. B. & STRETTON, R. G. Action of Quinacillin on Staphylococcus aureus. Nature 202, 1217 (1964).","journal-title":"Nature"},{"key":"3139_CR21","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00044-017-1922-x","volume":"26","author":"SA Shintre","year":"2017","unstructured":"Shintre, S. A. et al. Synthesis, in vitro antimicrobial, antioxidant, and antidiabetic activities of thiazolidine\u2013quinoxaline derivatives with amino acid side chains. Med. Chem. Res. 26, 2141\u20132151 (2017).","journal-title":"Med. Chem. Res."},{"key":"3139_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.ejmech.2016.10.025","volume":"124","author":"M Hajri","year":"2016","unstructured":"Hajri, M. et al. Synthesis and evaluation of in vitro antiproliferative activity of new Ethyl 3-(arylethynyl) quinoxaline-2-carboxylate and pyrido [4, 3-b] quinoxalin-1 (2H)-one derivatives. Eur. J. Med. Chem. 124, 959\u2013966 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"3139_CR23","doi-asserted-by":"crossref","unstructured":"Achutha, L., Parameshwar, R., Reddy, B. M. & Babu, V. H. Microwave-assisted synthesis of some quinoxaline-incorporated Schiff bases and their biological evaluation. J. Chem. (2013).","DOI":"10.1155\/2013\/578438"},{"key":"3139_CR24","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.bmcl.2017.02.049","volume":"27","author":"M Quiliano","year":"2017","unstructured":"Quiliano, M. et al. New hydrazine and Hydrazide Quinoxaline 1, 4-di-N-oxide derivatives: in Silico ADMET, antiplasmodial and antileishmanial activity. Bioorg. Med. Chem. Lett. 27, 1820\u20131825 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"3139_CR25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.molstruc.2019.02.074","volume":"1184","author":"HM Patel","year":"2019","unstructured":"Patel, H. M. et al. Quinoxaline-PABA bipartite hybrid derivatization approach: design and search for antimicrobial agents. J. Mol. Struct. 1184, 562\u2013568 (2019).","journal-title":"J. Mol. Struct."},{"key":"3139_CR26","doi-asserted-by":"crossref","unstructured":"Ragab, A. et al. New prospective insecticidal agents based on Thiazolo [4, 5-b] Quinoxaline derivatives against cotton leafworm Spodoptera litura (Fabricius): design, synthesis, toxicological, morphology, histological, and biomedical studies. Pestic Biochem. Physiol 105943 (2024).","DOI":"10.1016\/j.pestbp.2024.105943"},{"key":"3139_CR27","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1039\/D4RA08096C","volume":"15","author":"DM Elsisi","year":"2025","unstructured":"Elsisi, D. M. et al. Synthesis and modification of novel thiazole-fused quinoxalines as new insecticidal agents against the cotton leafworm Spodoptera Litura: design, characterization, in vivo bio-evaluation, toxicological effectiveness, and study their mode of action. RSC Adv. 15, 1391\u20131406 (2025).","journal-title":"RSC Adv."},{"key":"3139_CR28","doi-asserted-by":"publisher","first-page":"27363","DOI":"10.1039\/D3RA04230H","volume":"13","author":"YA Ammar","year":"2023","unstructured":"Ammar, Y. A. et al. Design, green synthesis, and quorum sensing quenching potential of novel 2-oxo-pyridines containing a Thiophene\/furan scaffold and targeting a Las R gene on P. aeruginosa. RSC Adv. 13, 27363\u201327384 (2023).","journal-title":"RSC Adv."},{"key":"3139_CR29","doi-asserted-by":"publisher","unstructured":"Suwanhom, P. et al. Synthesis, Biological evaluation, and in silico studies of new acetylcholinesterase inhibitors based on quinoxaline scaffold. Molecules  26 at (2021). https:\/\/doi.org\/10.3390\/molecules26164895","DOI":"10.3390\/molecules26164895"},{"key":"3139_CR30","doi-asserted-by":"publisher","first-page":"106750","DOI":"10.1016\/j.bioorg.2023.106750","volume":"139","author":"P Sharma","year":"2023","unstructured":"Sharma, P., Gupta, G. D. & Asati, V. Design, synthesis and antidiabetic study of Triazole clubbed Indole derivatives as $\u03b1$-glucosidase inhibitors. Bioorg. Chem. 139, 106750 (2023).","journal-title":"Bioorg. Chem."},{"key":"3139_CR31","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/S0960-894X(03)00378-0","volume":"13","author":"X Collin","year":"2003","unstructured":"Collin, X., Sauleau, A. & Coulon, J. 1, 2, 4-Triazolo mercapto and aminonitriles as potent antifungal agents. Bioorg. Med. Chem. Lett. 13, 2601\u20132605 (2003).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"3139_CR32","doi-asserted-by":"publisher","first-page":"115138","DOI":"10.1016\/j.ejmech.2023.115138","volume":"249","author":"R Ayman","year":"2023","unstructured":"Ayman, R., Abusaif, M. S., Radwan, A. M., Elmetwally, A. M. & Ragab, A. Development of novel pyrazole, imidazo[1,2-b]pyrazole, and pyrazolo[1,5-a]pyrimidine derivatives as a new class of COX-2 inhibitors with Immunomodulatory potential. Eur. J. Med. Chem. 249, 115138 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"3139_CR33","doi-asserted-by":"publisher","unstructured":"Ragab, A., Fouad, S. A., Ammar, Y. A., Aboul-Magd, D. S. & Abusaif, M. S. Antibiofilm and anti-quorum-sensing activities of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as carbonic anhydrase I and II inhibitors: design, synthesis, radiosterilization, and molecular docking studies. Antibiotics  12 128  (2023). https:\/\/doi.org\/10.3390\/antibiotics12010128","DOI":"10.3390\/antibiotics12010128"},{"key":"3139_CR34","doi-asserted-by":"publisher","first-page":"100672","DOI":"10.1016\/j.rechem.2022.100672","volume":"4","author":"FC Asogwa","year":"2022","unstructured":"Asogwa, F. C. et al. Synthesis, characterization, DFT studies and molecular docking investigation of 2-oxo-ethyl piperidine pentanamide-derived sulfonamides as anti-diabetic agents. Results Chem. 4, 100672 (2022).","journal-title":"Results Chem."},{"key":"3139_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ejmech.2007.04.010","volume":"43","author":"I Kucukguzel","year":"2008","unstructured":"Kucukguzel, I., Tatar, E., Kucukguzel, S. G., Rollas, S. & De Clercq, E. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy) methyl]-4-alkyl\/aryl-2, 4-dihydro-3H-1, 2, 4-triazole-3-thiones and evaluation as antiviral\/anti-HIV and anti-tuberculosis agents. Eur. J. Med. Chem. 43, 381\u2013392 (2008).","journal-title":"Eur. J. Med. Chem."},{"key":"3139_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0014-827X(01)01176-4","volume":"57","author":"E Palaska","year":"2002","unstructured":"Palaska, E., \u015eahin, G., Kelicen, P., Durlu, N. T. & Altinok, G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazole-3-thiones. Farm 57, 101\u2013107 (2002).","journal-title":"Farm"},{"key":"3139_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejmech.2008.03.006","volume":"44","author":"AT Mavrova","year":"2009","unstructured":"Mavrova, A. T., Wesselinova, D., Tsenov, Y. A. & Denkova, P. Synthesis, cytotoxicity and effects of some 1, 2, 4-triazole and 1, 3, 4-thiadiazole derivatives on immunocompetent cells. Eur. J. Med. Chem. 44, 63\u201369 (2009).","journal-title":"Eur. J. Med. Chem."},{"key":"3139_CR38","first-page":"596","volume":"140","author":"J Haber","year":"2001","unstructured":"Haber, J. Present status and perspectives on antimycotics with systemic effects. Cas Lek Cesk. 140, 596\u2013604 (2001).","journal-title":"Cas Lek Cesk."},{"key":"3139_CR39","doi-asserted-by":"publisher","unstructured":"Mahmood, S., Khan, S. G., Rasul, A., Christensen, J. B. & Abourehab, M. A. S. Ultrasound Assisted Synthesis and In Silico Modelling of 1,2,4-Triazole Coupled Acetamide Derivatives of 2-(4-Isobutyl phenyl)propanoic acid as Potential Anticancer Agents. Molecules  27  (2022). https:\/\/doi.org\/10.3390\/molecules27227984","DOI":"10.3390\/molecules27227984"},{"key":"3139_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.mencom.2023.06.033","volume":"33","author":"GV Nguyen","year":"2023","unstructured":"Nguyen, G. V. et al. Novel sulfonamide-functionalized arylidene indolones as potent $\u03b1$-glucosidase inhibitors: synthesis, characterization, and in vitro and in Silico studies. Mendeleev Commun. 33, 543\u2013545 (2023).","journal-title":"Mendeleev Commun."},{"key":"3139_CR41","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.jksus.2021.101401","volume":"33","author":"M Taha","year":"2021","unstructured":"Taha, M. et al. Synthesis, characterization, biological evaluation, and kinetic study of Indole base sulfonamide derivatives as acetylcholinesterase inhibitors in search of potent anti-Alzheimer agent. J. King Saud Univ. 33, 101401 (2021).","journal-title":"J. King Saud Univ."},{"key":"3139_CR42","first-page":"741","volume":"10","author":"M Mirian","year":"2011","unstructured":"Mirian, M. et al. Synthesis and cytotoxic evaluation of some novel Sulfonamidederivativesagainst a few human cancer cells. Iran. J. Pharm. Res. IJPR. 10, 741 (2011).","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"3139_CR43","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.bmcl.2004.06.023","volume":"14","author":"JT Link","year":"2004","unstructured":"Link, J. T. et al. Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulators. Bioorg. Med. Chem. Lett. 14, 4169\u20134172 (2004).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"3139_CR44","doi-asserted-by":"crossref","unstructured":"El-Kalyoubi, S. A. et al. One-pot synthesis and molecular modeling studies of new bioactive spiro-oxindoles based on uracil derivatives as SARS-CoV-2 inhibitors targeting RNA polymerase and spike glycoprotein. Pharmaceuticals 15, (2022).","DOI":"10.3390\/ph15030376"},{"key":"3139_CR45","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s11030-022-10387-8","volume":"26","author":"N Jeelan Basha","year":"2022","unstructured":"Jeelan Basha, N., Basavarajaiah, S. M. & Shyamsunder, K. Therapeutic potential of pyrrole and pyrrolidine analogs: an update. Mol. Divers. 26, 2915\u20132937 (2022).","journal-title":"Mol. Divers."},{"key":"3139_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s41061-021-00347-5","volume":"379","author":"G Li Petri","year":"2021","unstructured":"Li Petri, G. et al. Pyrrolidine in drug discovery: A versatile scaffold for novel biologically active compounds. Top. Curr. Chem. 379, 34 (2021).","journal-title":"Top. Curr. Chem."},{"key":"3139_CR47","doi-asserted-by":"publisher","first-page":"110094","DOI":"10.1016\/j.cclet.2024.110094","volume":"36","author":"A Liao","year":"2025","unstructured":"Liao, A. et al. Pyrrole and pyrrolidine analogs: the promising scaffold in discovery of pesticides. Chin. Chem. Lett. 36, 110094 (2025).","journal-title":"Chin. Chem. Lett."},{"key":"3139_CR48","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1007\/s00044-013-0524-5","volume":"22","author":"MH Helal","year":"2013","unstructured":"Helal, M. H., Abbas, S. Y., Salem, M. A., Farag, A. A. & Ammar, Y. A. Synthesis and characterization of new types of 2-(6-methoxy-2-naphthyl)propionamide derivatives as potential antibacterial and antifungal agents. Med. Chem. Res. 22, 5598\u20135609 (2013).","journal-title":"Med. Chem. Res."},{"key":"3139_CR49","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1080\/07391102.2021.1989036","volume":"40","author":"ESAEH Khattab","year":"2022","unstructured":"Khattab, E. S. A. E. H., Ragab, A., Abol-Ftouh, M. A. & Elhenawy, A. A. Therapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral Spike proteins. J. Biomol. Struct. Dyn. 40, 13291\u201313309 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"3139_CR50","doi-asserted-by":"publisher","unstructured":"Fayed, E. A., Ragab, A., Ezz Eldin, R. R., Bayoumi, A. H. & Ammar, Y. A. In vivo screening and toxicity studies of Indolinone incorporated thiosemicarbazone, thiazole and Piperidinosulfonyl moieties as anticonvulsant agents. Bioorg. Chem. 105300 https:\/\/doi.org\/10.1016\/j.bioorg.2021.105300 (2021).","DOI":"10.1016\/j.bioorg.2021.105300"},{"key":"3139_CR51","doi-asserted-by":"publisher","first-page":"141879","DOI":"10.1016\/j.molstruc.2025.141879","volume":"1334","author":"OAA Ali","year":"2025","unstructured":"Ali, O. A. A., Ragab, A., Ammar, Y. A. & Abusaif, M. S. Discovery of new thiazolidin-4-one and thiazole nucleus incorporation Sulfaguanidine scaffold as new class of antimicrobial agents: design, synthesis, in Silico ADMET, and Docking simulation. J. Mol. Struct. 1334, 141879 (2025).","journal-title":"J. Mol. Struct."},{"key":"3139_CR52","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.1039\/D3RA00887H","volume":"13","author":"RR Raslan","year":"2023","unstructured":"Raslan, R. R. et al. Evaluation of the anti-proliferative activity of 2-oxo-pyridine and 1\u2032H-spiro-pyridine derivatives as a new class of EGFRWt and VEGFR-2 inhibitors with apoptotic inducers. RSC Adv. 13, 10440\u201310458 (2023).","journal-title":"RSC Adv."},{"key":"3139_CR53","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1039\/D4RA08271K","volume":"15","author":"A Ragab","year":"2025","unstructured":"Ragab, A. Recent advances in the synthesis, reaction, and bio-evaluation potential of purines as precursor pharmacophores in chemical reactions: a review. RSC Adv. 15, 3607\u20133645 (2025).","journal-title":"RSC Adv."},{"key":"3139_CR54","first-page":"37","volume":"5","author":"MS Wassel","year":"2020","unstructured":"Wassel, M. S., Gamal Eldin, M. M., Ragab, W., Elhag Ali, A. A. M., Ammar, A. & G. & Antiviral activity of Adamantane-Pyrazole derivatives against foot and mouth disease virus infection in vivo and in vitro with molecular Docking study. J. Appl. Vet. Sci. 5, 37\u201346 (2020).","journal-title":"J. Appl. Vet. Sci."},{"key":"3139_CR55","doi-asserted-by":"publisher","first-page":"22792","DOI":"10.1038\/s41598-023-50130-3","volume":"13","author":"YM Abdel-Baky","year":"2023","unstructured":"Abdel-Baky, Y. M. et al. Developing a new multi-featured chitosan-quinoline schiff base with potent antibacterial, antioxidant, and antidiabetic activities: design and molecular modeling simulation. Sci. Rep. 13, 22792 (2023).","journal-title":"Sci. Rep."},{"key":"3139_CR56","doi-asserted-by":"publisher","first-page":"31908","DOI":"10.1039\/D3RA05066A","volume":"13","author":"MMF Ismail","year":"2023","unstructured":"Ismail, M. M. F. et al. Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers. RSC Adv. 13, 31908\u201331924 (2023).","journal-title":"RSC Adv."},{"key":"3139_CR57","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s13738-020-02082-y","volume":"18","author":"MS Abusaif","year":"2021","unstructured":"Abusaif, M. S. et al. Effect of different acceptors on N-hexyl carbazole moiety for dye-sensitized solar cells: design, characterization, molecular structure, and DSSC fabrications. J. Iran. Chem. Soc. 18, 949\u2013960 (2021).","journal-title":"J. Iran. Chem. Soc."},{"key":"3139_CR58","doi-asserted-by":"crossref","unstructured":"El-Gaby, M. S. A., Ammar, Y. A., Ismail, M. A., Ragab, A. & Abusaif, M. S. Synthesis, characterization, and biological target prediction of novel 1,3-dithiolo[4,5- B ]quinoxaline and thiazolo[4,5- B ]quinoxaline derivatives. Heterocycl Commun 29, (2023).","DOI":"10.1515\/hc-2022-0170"},{"key":"3139_CR59","doi-asserted-by":"publisher","first-page":"105207","DOI":"10.1016\/j.jtice.2023.105207","volume":"153","author":"MS Abusaif","year":"2023","unstructured":"Abusaif, M. S. et al. Novel Water-soluble quinoxaline-2,3-dione-6-sulfohydrazide derivatives as efficient acid corrosion inhibitors: design, characterization, experimental, and theoretical studies. J. Taiwan. Inst. Chem. Eng. 153, 105207 (2023).","journal-title":"J. Taiwan. Inst. Chem. Eng."},{"key":"3139_CR60","doi-asserted-by":"publisher","first-page":"106307","DOI":"10.1016\/j.bioorg.2022.106307","volume":"131","author":"A Ragab","year":"2023","unstructured":"Ragab, A. et al. Development of new spiro[1,3]dithiine-4,11\u2032-indeno[1,2-b]quinoxaline derivatives as S. aureus sortase A inhibitors and radiosterilization with molecular modeling simulation. Bioorg. Chem. 131, 106307 (2023).","journal-title":"Bioorg. Chem."},{"key":"3139_CR61","doi-asserted-by":"publisher","first-page":"12589","DOI":"10.1039\/D3RA01635H","volume":"13","author":"MA Ismail","year":"2023","unstructured":"Ismail, M. A., Abusaif, M. S., El-Gaby, M. S. A., Ammar, Y. A. & Ragab, A. A new class of anti-proliferative activity and apoptotic inducer with molecular Docking studies for a novel of 1,3-dithiolo[4,5- B ]quinoxaline derivatives hybrid with a sulfonamide moiety. RSC Adv. 13, 12589\u201312608 (2023).","journal-title":"RSC Adv."},{"key":"3139_CR62","doi-asserted-by":"publisher","DOI":"10.1108\/PRT-12-2022-0141","author":"AA Ali","year":"2023","unstructured":"Ali, A. A. et al. Design, characterization, theoretical studies, and dyeing properties of new novel Diazo salicylaldehyde schiff base catalyzed with ceric (IV) ammonium nitrate (CAN) as an eco-friendly catalyst. Pigment Resin Technol. https:\/\/doi.org\/10.1108\/PRT-12-2022-0141 (2023).","journal-title":"Pigment Resin Technol."},{"key":"3139_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s13369-023-08073-4","author":"GA Abd-elmaksoud","year":"2023","unstructured":"Abd-elmaksoud, G. A. et al. Characterization, DFT computational study, and evaluation the performance of some new N-Amino pyridinone schiff base catalyzed with Ceric(IV) ammonium nitrate (CAN) as corrosion inhibitors in some petroleum applications. Arab. J. Sci. Eng. https:\/\/doi.org\/10.1007\/s13369-023-08073-4 (2023).","journal-title":"Arab. J. Sci. Eng."},{"key":"3139_CR64","doi-asserted-by":"publisher","first-page":"117499","DOI":"10.1016\/j.ejmech.2025.117499","volume":"290","author":"A Ragab","year":"2025","unstructured":"Ragab, A., Ayman, R., Salem, M. A., Ammar, Y. A. & Abusaif, M. S. Unveiling a novel pyrazolopyrimidine scaffold as a dual COX-2\/5-LOX inhibitor with Immunomodulatory potential: design, synthesis, target prediction, anti-inflammatory activity, and ADME-T with Docking simulation. Eur. J. Med. Chem. 290, 117499 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"3139_CR65","doi-asserted-by":"publisher","first-page":"135671","DOI":"10.1016\/j.molstruc.2023.135671","volume":"1287","author":"HA Mohamed","year":"2023","unstructured":"Mohamed, H. A. et al. Discovery a novel of thiazolo[3,2-a]pyridine and pyrazolo[3,4-d]thiazole derivatives as DNA gyrase inhibitors; design, synthesis, antimicrobial activity, and some in-silico ADMET with molecular Docking study. J. Mol. Struct. 1287, 135671 (2023).","journal-title":"J. Mol. Struct."},{"key":"3139_CR66","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1080\/104265090889396","volume":"180","author":"CA Obafemi","year":"2005","unstructured":"Obafemi, C. A. & Akinpelu, D. A. Synthesis and antimicrobial activity of some 2(1H)-quinoxalinone-6-sulfonyl derivatives. Phosphorus Sulfur Silicon Relat. Elem. 180, 1795\u20131807 (2005).","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"3139_CR67","doi-asserted-by":"crossref","unstructured":"El-Din, N. S. Synthesis of some sulfonamide derivatives with potential antibacterial activity. Chem Heterocycl. Compd 523\u2013528 (2000).","DOI":"10.1007\/BF02269544"},{"key":"3139_CR68","doi-asserted-by":"publisher","first-page":"103497","DOI":"10.1016\/j.arabjc.2021.103497","volume":"15","author":"A Ragab","year":"2022","unstructured":"Ragab, A. et al. Design, synthesis of new novel quinoxalin-2(1H)-one derivatives incorporating hydrazone, hydrazine, and pyrazole moieties as antimicrobial potential with in-silico ADME and molecular Docking simulation. Arab. J. Chem. 15, 103497 (2022).","journal-title":"Arab. J. Chem."},{"key":"3139_CR69","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00044-021-02765-y","volume":"30","author":"YA Ammar","year":"2021","unstructured":"Ammar, Y. A. et al. Carboxamide appended Quinoline moieties as potential anti-proliferative agents, apoptotic inducers and Pim-1 kinase inhibitors. Med. Chem. Res. 30, 1649\u20131668 (2021).","journal-title":"Med. Chem. Res."},{"key":"3139_CR70","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.1016\/S0040-4020(01)00877-8","volume":"57","author":"G Pistia-Brueggeman","year":"2001","unstructured":"Pistia-Brueggeman, G. & Hollingsworth, R. I. A Preparation and screening strategy for glycosidase inhibitors. Tetrahedron 57, 8773\u20138778 (2001).","journal-title":"Tetrahedron"},{"key":"3139_CR71","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12906-016-1452-y","volume":"16","author":"MN Wickramaratne","year":"2016","unstructured":"Wickramaratne, M. N., Punchihewa, J. C. & Wickramaratne, D. B. M. In-vitro alpha amylase inhibitory activity of the leaf extracts of adenanthera pavonina. BMC Complement. Altern. Med. 16, 466 (2016).","journal-title":"BMC Complement. Altern. Med."},{"key":"3139_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Andres, V. & Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395 (1961).","journal-title":"Biochem. Pharmacol."},{"key":"3139_CR73","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/10406638.2021.2015402","volume":"43","author":"HF Rizk","year":"2023","unstructured":"Rizk, H. F., El-Borai, M. A., Ragab, A., Ibrahim, S. A. & Sadek, M. E. A novel of Azo-Thiazole moiety alternative for Benzidine-Based pigments: design, synthesis, characterization, biological evaluation, and molecular Docking study. Polycycl. Aromat. Compd. 43, 500\u2013522 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"3139_CR74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/cbdd.14154","volume":"101","author":"YA Ammar","year":"2023","unstructured":"Ammar, Y. A. et al. Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: antimicrobial and hemolytic activities against uropathogenic isolates with molecular Docking study. Chem. Biol. Drug Des. 101, 245\u2013270 (2023).","journal-title":"Chem. Biol. Drug Des."},{"key":"3139_CR75","doi-asserted-by":"publisher","first-page":"134443","DOI":"10.1016\/j.molstruc.2022.134443","volume":"1274","author":"MM Abdelgalil","year":"2023","unstructured":"Abdelgalil, M. M., Ammar, Y. A., Ali, E., Ali, G. A. M., Ragab, A. & A. K. & A novel of Quinoxaline derivatives tagged with pyrrolidinyl scaffold as a new class of antimicrobial agents: design, synthesis, antimicrobial activity, and molecular Docking simulation. J. Mol. Struct. 1274, 134443 (2023).","journal-title":"J. Mol. Struct."},{"key":"3139_CR76","doi-asserted-by":"publisher","first-page":"108097","DOI":"10.1016\/j.compbiolchem.2024.108097","volume":"111","author":"HK Thabet","year":"2024","unstructured":"Thabet, H. K. et al. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting $\u03b1$-glucosidase, $\u03b1$-amylase, and PPAR-$\u03b3$: design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus. Comput. Biol. Chem. 111, 108097 (2024).","journal-title":"Comput. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03139-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:03:08Z","timestamp":1748948588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03139-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03139-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19409"}}